E
Ennapadam Venkatraman
Researcher at Memorial Sloan Kettering Cancer Center
Publications - 100
Citations - 18639
Ennapadam Venkatraman is an academic researcher from Memorial Sloan Kettering Cancer Center. The author has contributed to research in topics: Survival rate & Lung cancer. The author has an hindex of 64, co-authored 100 publications receiving 17861 citations. Previous affiliations of Ennapadam Venkatraman include University of California, San Francisco.
Papers
More filters
Journal ArticleDOI
Circular binary segmentation for the analysis of array-based DNA copy number data.
TL;DR: A modification ofbinary segmentation is developed, which is called circular binary segmentation, to translate noisy intensity measurements into regions of equal copy number in DNA sequence copy number.
Journal ArticleDOI
A faster circular binary segmentation algorithm for the analysis of array CGH data
TL;DR: A hybrid approach to obtain the P-value of the test statistic in linear time is presented and it is shown that the substantial gain in speed with only a negligible loss in accuracy and that the stopping rule further increases speed.
Journal ArticleDOI
High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients
Michael J. Zelefsky,Zvi Fuks,Margie Hunt,Yoshiya Yamada,Christine Marion,C. Clifton Ling,Howard Amols,Ennapadam Venkatraman,Steven A. Leibel +8 more
TL;DR: These data demonstrate the feasibility of high-dose IMRT in a large number of patients and demonstrate that short-term PSA control rates seem to be at least comparable to those achieved with three-dimensional conformal radiotherapy at similar dose levels.
Journal ArticleDOI
Bronchioloalveolar Pathologic Subtype and Smoking History Predict Sensitivity to Gefitinib in Advanced Non–Small-Cell Lung Cancer
Vincent A. Miller,Mark G. Kris,Neelain Shah,Jyoti D. Patel,Christopher G. Azzoli,Jorge Gomez,Lee M. Krug,William Pao,Naiyer A. Rizvi,Barbara Pizzo,Leslie B. Tyson,Ennapadam Venkatraman,Leah Ben-Porat,Natalie Memoli,Manreen Zakowski,Valerie W. Rusch,Robert T. Heelan +16 more
TL;DR: The data suggest that individuals in whom gefitinib is efficacious are more likely to have adenocarcinomas of the bronchioloalveolar subtype and to be never smokers, and suggest that NSCLC has a different biology in patients who never smoked and those with bronchiola alveolar carcinoma.
Journal ArticleDOI
High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer
Michael J. Zelefsky,Zvi Fuks,Margie Hunt,Henry J. Lee,Danna Lombardi,C. Clifton Ling,Victor E. Reuter,Ennapadam Venkatraman,Steven A. Leibel +8 more
TL;DR: Sophisticated conformal radiotherapy techniques with high dose 3-D conformal and intensity modulated radiation therapy improve the biochemical outcome in patients with favorable, intermediate and unfavorable risk prostate cancer.